These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19466903)

  • 81. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model.
    Carneiro JS; Bento AS; Bacic D; Nearing BD; Rajamani S; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1364-9. PubMed ID: 26331943
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.
    Tajiri K; Guichard JB; Qi X; Xiong F; Naud P; Tardif JC; Costa AD; Aonuma K; Nattel S
    Cardiovasc Res; 2019 Dec; 115(14):1975-1985. PubMed ID: 31119260
    [TBL] [Abstract][Full Text] [Related]  

  • 84. What niche will newer class III antiarrhythmic drugs occupy?
    Singh BN; Sarma JS
    Curr Cardiol Rep; 2001 Jul; 3(4):314-23. PubMed ID: 11406090
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.
    Fragakis N; Koskinas KC; Vassilikos V
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1412-20. PubMed ID: 25138058
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
    Neumann T; Hölschermann H
    Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
    [No Abstract]   [Full Text] [Related]  

  • 87. Atrial-selective approaches for the treatment of atrial fibrillation.
    Ehrlich JR; Biliczki P; Hohnloser SH; Nattel S
    J Am Coll Cardiol; 2008 Feb; 51(8):787-92. PubMed ID: 18294561
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.
    Kato T; Iwasaki YK; Duker G; Fjellstrom O; Giordanetto F; Sundqvist M; Wallin A; Wang QD; Nattel S
    J Cardiovasc Electrophysiol; 2014 May; 25(5):531-536. PubMed ID: 24330029
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.
    Dobrev D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):195-206. PubMed ID: 19784635
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Chinese herb extract Wenxin Keli: atrial selectivity from the Far East.
    Kalifa J; Avula UM
    Heart Rhythm; 2012 Jan; 9(1):132-3. PubMed ID: 22116050
    [No Abstract]   [Full Text] [Related]  

  • 92. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 93. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.
    Aguilar M; Rose RA; Takawale A; Nattel S; Reilly S
    Cardiovasc Res; 2021 Jun; 117(7):1645-1661. PubMed ID: 33723575
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of pilsicainide, a pure sodium channel blocker, on spiral waves during atrial fibrillation: theoretical analysis by numerical simulation.
    Namba T; Ashihara T; Nakazawa K; Ohe T
    J Electrocardiol; 1999 Oct; 32(4):321-34. PubMed ID: 10549908
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics.
    Kanki H; Mitamura H; Takatsuki S; Sueyoshi K; Shinagawa K; Sato T; Ogawa S
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):475-82. PubMed ID: 9926279
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Atrial-selective block of sodium channels by acehytisine in rabbit myocardium.
    Fan X; Wang C; Wang N; Ou X; Liu H; Yang Y; Dang X; Zeng X; Cai L
    J Pharmacol Sci; 2016 Dec; 132(4):235-243. PubMed ID: 27107824
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis.
    Hu D; Barajas-Martínez H; Burashnikov A; Panama BK; Cordeiro JM; Antzelevitch C
    Int J Cardiol; 2016 Mar; 207():326-34. PubMed ID: 26820362
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
    Nattel S; Dobrev D
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
    [No Abstract]   [Full Text] [Related]  

  • 100. Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties.
    Nattel S; Liu L; St-Georges D
    Cardiovasc Res; 1998 Mar; 37(3):627-35. PubMed ID: 9659446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.